Sandoz Group (OTCMKTS:SDZNY) Hits New 12-Month High – Should You Buy?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $68.61 and last traded at $68.52, with a volume of 15160 shares traded. The stock had previously closed at $66.53.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Barclays upgraded Sandoz Group to a “strong-buy” rating in a report on Monday, October 13th. Jefferies Financial Group lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Sandoz Group Stock Up 3.0%

The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.62. The company has a fifty day moving average of $61.09 and a 200-day moving average of $55.53.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.